Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study (BECARES)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03810599|
Recruitment Status : Recruiting
First Posted : January 18, 2019
Last Update Posted : January 18, 2019
|Condition or disease||Intervention/treatment||Phase|
|Coronary Artery Disease||Other: Early cardiac rehabilitation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||870 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||Pre-post comparison.|
|Masking:||None (Open Label)|
|Official Title:||Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study|
|Actual Study Start Date :||September 9, 2013|
|Estimated Primary Completion Date :||February 2019|
|Estimated Study Completion Date :||February 2029|
Early cardiac rehabilitation
Single Group: 5 week cardiac rehabilitation programme. Pre-post comparison.
Other: Early cardiac rehabilitation
This is an early cardiac rehabilitation programme starting 1-2 weeks after hospital discharge (Phase 2A rehabilitation). The programme provided by a multidisciplinary team includes individual counseling, educational sessions and discussion in groups, and exercise training sessions three days a week for five weeks.
For additional analysis there will be a comparison group that did not receive the intervention for practical reasons.
- Time to composite of total mortality, and hospitalization for heart failure and atherothrombotic disease (including non-fatal MI, unstable angina and stroke). [ Time Frame: Up to 10 years ]Time to combined endpoint from inclusion.
- Change in Self-reported health [ Time Frame: Immediately after the 5 week intervention, and at 9, 31, 57 and 109 weeks ]The EuroQol 5-dimensions-5 level questionnaire (EQ-5D-5L) is an 5 item self-report-questionnaire assessing self-reported health. The respondent rates each item on a 5-point scale ranging from 1(indicating no problem) to 5 (indicating extreme problems). This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
- Change in self-reported global health [ Time Frame: Immediately after the 5 week intervention, and at 9, 31, 57 and 109 weeks ]The VAS scale from the EQ-5D-5L assess global health. The scale goes from 0 to 100 were lower score indicates worse health.
- Change in post traumatic growth [ Time Frame: Immediately after the 5 week intervention, and at 9, 31, 57 and 109 weeks ]The Posttraumatic Growth Inventory-Short Form (PTGI-SF) is a 10 item scale measuring post traumatic growth. The respondent rates each item on a 6-point scale ranging from 0 (I did not experience this change as a result of my crisis) to 5 (I experienced this change to a very great degree as a result of my crisis). The scale is scored by adding all the responses.Individual factors are scored by adding responses to items on each factor. Factors are indicated by the Roman numerals after each item.
- Nicotine dependence [ Time Frame: Immediately after the 5 week intervention, and at 9, 31, 57 and 109 weeks ]The Fagerström test
- Change in anxiety and depression [ Time Frame: Immediately after the 5 week intervention, and at 9, 31, 57 and 109 weeks ]The Hospital Anxiety and Depression Scale (HADS) is a fourteen item scale where seven of the items relate to anxiety and seven relate to depression. The respondent rates each item on a 4-point scale ranging from 0 (absence) to 3 (extreme presence). The total score is 42 (21 per subscale).
- Change in physical and mental dimensions of health [ Time Frame: Immediately after the 5 week intervention, and at 9, 31, 57 and 109 weeks ]The Short Form Health Survey (SF-12) include 12 items with 3 to 5 response levels. It generates two health indices: mental health and physical health. The score range between 0 and 100, with 100 representing the highest level of health
- Change in health status following myocardial infarction [ Time Frame: Immediately after the 5 week intervention, and at 9, 31, 57 and 109 weeks ]The Myocardial Infarction Dimensional Assessment Scale (MIDAS) is a PRO measure developed and validated to specifically measure the health status of individuals who have suffered a myocardial infarction. It consist of 7 domains, and is a 35 item scale where respondents rate each item on a 5-point scale ranging from 1 (never) to 5 (always). The function of the MIDAS is to indicate the extent of ill health in each of the seven domains assessed, therefore each dimension is scored separately using a simple scoring methodology.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03810599
|Contact: Tone M Norekvål, PhDfirstname.lastname@example.org|
|Contact: Nina B Fålun, MScemail@example.com|
|Haukeland University Hospital||Recruiting|
|Bergen, Norway, 5021|
|Contact: Tone M Norekvål, PhD +4799044635 firstname.lastname@example.org|
|Principal Investigator:||Tone M Norekvål, PhD||Haukeland University Hospital|